EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review

Liangliang Liu, Desheng Yuan, Huaxing Zhao, Bacui Yu iD

Birth Defects Research · 2026

DOI: 10.1002/bdr2.70109 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Birth Defects Research, 2026. Verfasst von Liangliang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Kangbao Biological Products Co. Ltd., Changzhi, Shanxi Province, China. Hauptthemen laut MEDLINE: Afibrinogenemia, Fibrinogen, Mutation. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Shanxi Provincial Key Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Congenital afibrinogenemia is an extremely rare autosomal recessive bleeding disorder with an estimated incidence of one in one million, caused by mutations in the fibrinogen‐encoding genes.

Methods

We report a genetically confirmed case of FGA‐related congenital afibrinogenemia in a 9‐year‐old female child. Comprehensive coagulation analysis revealed undetectable fibrinogen activity (FIB:C, < 0.2 g/L) as measured by the Clauss assay, along with significantly prolonged prothrombin time, activated partial thromboplastin time, and thrombin time.

Results

Next‐generation sequencing targeting coagulation‐related genes identified compound heterozygous mutations in FGA (NM_000508): a paternal nonsense mutation c.502C>T (p.Arg168Ter) in Exon 4 and a maternal frameshift mutation c.668delT (p.Leu223ArgfsX2) in Exon 5. These pathogenic variants were further confirmed by Sanger sequencing in the proband and her parents, which demonstrated that the proband carried the two FGA variants in a compound heterozygous state, with paternal inheritance of c.502C>T and maternal inheritance of c.668delT.

Conclusion

This case expands the genotype–phenotype correlation database for fibrinogen disorders and underscores the necessity of molecular diagnosis for congenital coagulation defects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AfibrinogenemiaFibrinogenMutationHumansFemaleHeterozygoteChildExonsPedigree

Stichwörter der Autor:innen

FGAcase reportcompound heterozygous mutationcongenital afibrinogenemia

Substanzen

FibrinogenFGA protein, human

Autor:innen und Institutionen

  • Shanxi Kangbao Biological Products Co. Ltd., Changzhi, Shanxi Province, China.
  • Beijing Hiphar Medical Technology Co. Ltd., Beijing, China.
  • Department of Burn Surgery, The Second People's Hospital of Changzhi, Changzhi, Shanxi Province, China.
  • Department of Pharmacy, The Second People's Hospital of Changzhi, Changzhi, Shanxi Province, China.

ORCID-Profile: Bacui Yu

Förderung

  • Shanxi Provincial Key Research and Development Project

Zitieren

APA

Liu, L., Yuan, D., Zhao, H., & Yu, B. (2026). Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review. Birth Defects Research. https://doi.org/10.1002/bdr2.70109

Vancouver

Liu L, Yuan D, Zhao H, Yu B. Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review. Birth Defects Research. 2026. doi:10.1002/bdr2.70109

BibTeX
@article{Liu2026,
  author = {Liu, Liangliang and Yuan, Desheng and Zhao, Huaxing and Yu, Bacui},
  title = {Compound Heterozygous Mutations in FGA Cause Congenital Afibrinogenemia: A Case Report and Literature Review},
  journal = {Birth Defects Research},
  year = {2026},
  doi = {10.1002/bdr2.70109}
}
Kostenlos starten →